{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:44:13Z","timestamp":1788572653999,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jns.2020.116777","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:21:52Z","timestamp":1584577312000},"page":"116777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Bendamustine\u2013rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy"],"prefix":"10.1016","volume":"413","author":[{"given":"F.","family":"Massa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zuppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Demichelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garnero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Briani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schenone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.116777_bb0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.21577","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy","volume":"65","author":"Dalakas","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.116777_bb0010","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy","volume":"80","author":"Leger","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2020.116777_bb0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jnnp-2017-316715","article-title":"Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features","volume":"89","author":"Svahn","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2020.116777_bb0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jns.12287","article-title":"Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy with associated diseases","volume":"23","author":"Roux","year":"2018","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jns.2020.116777_bb0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jnnp.2009.188912","article-title":"Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature","volume":"82","author":"Benedetti","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2020.116777_bb0030","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/01.WNL.0000134606.50529.C7","article-title":"Sustained remission of CIDP associated with Evans syndrome","volume":"63","author":"Knecht","year":"2004","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2020.116777_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-1331.2004.00911.x","article-title":"Rituximab-responsive CIDP","volume":"11","author":"Briani","year":"2004","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.116777_bb0040","doi-asserted-by":"crossref","first-page":"vi155","DOI":"10.1093\/annonc\/mdt298","article-title":"Waldenstrom\u2019s macroglobulinaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Buske","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jns.2020.116777_bb0045","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2013.087213","article-title":"Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients","volume":"98","author":"Hospital","year":"2013","journal-title":"Haematologica."},{"key":"10.1016\/j.jns.2020.116777_bb0050","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial","volume":"381","author":"Rummel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2020.116777_bb0055","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.clml.2016.04.004","article-title":"Anti myelin-associated-glycoprotein antibody peripheral neuropathy response to combination chemoimmunotherapy with bendamustine\/rituximab in a patient with biclonal IgM \u03ba and IgM \u03bb: case report and review of the literature","volume":"16","author":"Gomez","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.jns.2020.116777_bb0060","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.116777_bb0065","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/ene.13387","article-title":"Anti-sulfatide\/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies","volume":"24","author":"Boso","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.116777_bb0070","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2020.116777_bb0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/14737175.2017.1340832","article-title":"Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan","volume":"17","author":"Nobile-Orazio","year":"2017","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jns.2020.116777_bb0080","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2015-01-553974","article-title":"How I treat Waldenstr\u00f6m macroglobulinemia","volume":"126","author":"Treon","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.jns.2020.116777_bb0085","article-title":"Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"5","author":"Mahdi-Rogers","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2020.116777_bb0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1529-8027.2011.00343.x","article-title":"Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy","volume":"16","author":"Gruson","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jns.2020.116777_bb0095","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.3109\/10428194.2015.1012714","article-title":"Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenstr\u00f6m macroglobulinemia","volume":"56","author":"Tedeschi","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jns.2020.116777_bb0100","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3324\/haematol.2017.186569","article-title":"Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large b-cell non-hodgkin lymphoma: A phase ii multicenter study of the fondazione italiana linfomi","volume":"103","author":"Storti","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jns.2020.116777_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000487850","article-title":"Beneficial effect of bendamustine in a patient with anti-MAG\/SGPG neuropathy and bing-neel syndrome associated with Waldenstr\u00f6m macroglobulinemia: a case report","volume":"10","author":"Ueki","year":"2018","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.jns.2020.116777_bb0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1200\/JCO.2008.17.7865","article-title":"Update on treatment recommendations from the fourth international workshop on Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"27","author":"Dimopoulos","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jns.2020.116777_bb0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jns.2017.04.015","article-title":"Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy","volume":"377","author":"Gazzola","year":"2017","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20301131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20301131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:50:01Z","timestamp":1758383401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20301131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":23,"alternative-id":["S0022510X20301131"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116777","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bendamustine\u2013rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116777"}}